Lobbying Activity Report

5076-26665

Organization: Biogen Canada Inc.
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? No
Associated registration: 9613-5076-1
Lobbying Activity date: 2023-05-31
Arranged a meeting: No
Posted date: 2023-06-15

In-house lobbyists who participated in the lobbying activity: Liliana Polcari
Farah Jivraj
Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Promoting the value of an integrated system for research and care for patients with rare progressive neuromuscular diseases like ALS and Spinal Muscular
Atrophy (SMA).
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
Promoting the value of Biogen Canada's innovative product portfolio, pipeline, and research and products related to biosimilars, depression, ophthalmology, Multiple Sclerosis and
other neuromuscular diseases to address patient needs.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Eric Tse
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: